Day

April 5, 2019
Purdue Pharma agreed to pay $270 million to the Oklahoma state attorney general on March 26, 2019 for its painkiller medication, OxyContin, for aggressively marketing its drug that led to an epidemic of deaths in the state. The settlement includes money that will establish addiction treatment and research centers and money that will go directly...
Read More
Bristol-Myers Squibb Co. and Otsuka Pharmaceutical Co. Ltd. have reached a confidential settlement regarding the drug Abilify with plaintiffs in the multi district litigation (MDL) on February 26, 2019. The drug is meant for antipsychotic purposes to treat schizophrenia and bipolar disorders. However, Abilify has also been known to cause side effects of compulsive behaviors,...
Read More